Long-Term Assets: The sum of all assets classified as non-current.
Artiva Biotherapeutics, Inc. (ARTV) had Long-Term Assets of $17.21M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-23.52M |
|
-- |
|
-- |
|
$24.43M |
|
$-24.43M |
|
$0.91M |
|
$-23.52M |
|
$-23.52M |
|
$-23.52M |
|
$-23.52M |
|
$-23.52M |
|
$-23.52M |
|
$-24.43M |
|
$-23.76M |
|
24.68M |
|
24.68M |
|
$-0.95 |
|
$-0.95 |
|
| Balance Sheet Financials | |
$88.74M |
|
$6.22M |
|
|
Long-Term Assets |
$17.21M |
$105.95M |
|
$10.88M |
|
-- |
|
$7.23M |
|
$18.11M |
|
$87.85M |
|
$87.85M |
|
$87.85M |
|
24.72M |
|
| Cash Flow Statement Financials | |
$-20.95M |
|
$15.32M |
|
$-0.11M |
|
$27.16M |
|
$21.42M |
|
$-5.75M |
|
$1.59M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
8.16 |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-21.19M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-26.77% |
|
-26.77% |
|
-22.19% |
|
-26.77% |
|
$3.55 |
|
$-0.86 |
|
$-0.85 |
|